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Abstract 
A special emphasis is placed in this paper on developing countries where series of 
constraints limit the provision of access to health care, including shortage of related 
skilled labor. The need of human resources in healthcare in relation to the deployment of 
new advanced health technologies is expressed in both developed and developing 
economies. Emergent and developed countries have generated new instruments to limit 
the negative effects of the constraints facing human resources in healthcare, while this 
process is quite new in developing countries. The expansion of access to new health 
technologies could be achieved within the world global health system framework 
requirements of increasingly needed human resources and skills are shown. Empirical 
evidence and data analysis are also provided and support the trends taking place in the 
health workforce in developing countries.  
Keywords: Medical Human Resources-Medical Technologies-Density of Medical 
Personnel-Global Health Systems.  
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Introduction
This version is the final one as it replaces the one connected to it on the MPRA site. This 
paper recognizes that advanced technologies have promising impacts on the health 
systems in both developed and developing economies. But, in developing countries, 
health technologies still have limited impacts. In addition, the need for highly qualified 
medical human resources is pressured by emigration and mobility that accentuate 
shortages in quantity and in up to date knowledge (Heller, 1998; Gutam et al., 2010 and 
WHO, 2000).  It is recognized also that human resources are major players in this 
domain. Local health addresses the issues of local specific health problems (neglected 
diseases) and diseases that are not generally addressed by the global health system 
(Ghadar and Hardy, 2006; Allotey, Reidpath, & Pokhrel, 2010). Qualified human 
resources are increasingly becoming crucial given these constraints, the advancement of 
technologies and their potential positive impacts on health. This is aggravated by the 
emigration of medical staff from developing to developed economies (Driouchi, 2014; 
Driouchi and Kadiri, 2010; Rutten, 2007). The latter limitation is related to the risks and 
uncertainties faced by the overall chain of applying new technologies and new 
discoveries to human health with human resources playing an important role. There are 
different types of risks and uncertainties faced by the populations with limitations in the 
area of safety and anticipation of sources of new hazards. In this area, developed 
economies can engage quicker than developing economies in identifying new sources of 
risks, safety nets with the required means to engage in further compensatory mechanisms. 
The recent cases of some pharmaceuticals with lethal side effects provide examples about 
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the level of responses in both types of economies. Again, in all these stages, qualified 
human resources are essential.  
The first part of this paper looks at global trends taking place in world human resources 
in health systems, based on a literature review. The second part focuses on the major 
factors affecting the health workforce, based on empirical evidence and data analysis.   
I. Literature Review  
Different authors show how advanced new technologies are changing the performance 
and the higher success rates of the Health Care Systems (HCS) and impose also new 
requirements for human resources. The 2006 report of the World Health Organization 
(WHO, 2006) has already underlined the magnitude and extent of the importance of 
qualified human resources in all world health systems but especially in low income 
countries. Basic questions related to human resources in health are addressed in this 
important document.  
The World Health Organization (2010) defines HCS as the mechanisms that support 
health and provide health services. These services are not uniquely provided by machines 
but by increasingly knowledgeable human resources. New technologies in the field of 
health are referred to as medical technologies. The Office of Technological Assessment 
(1982) recognized technology as drugs, devices, medical and surgical procedures used in 
medical care and organizational and supportive systems through which care is provided. 
Thompson and Tebbens (2006) claim that vaccine against polio saved, for US alone, 
around $180 billion in the past 50 years. Health threats are constant and new technologies 
allow diagnosis, awareness, cures and therapies (UNAIDS, 2008). According to FDA 
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(2006), an average of eight to nine years is needed to test a drug before it is launched to 
public and even more for vaccines. These trends have been accentuating the roles of 
human resources and the skills needed at all levels of HCS, in all countries and globally. 
Branciard (2013) develops new means that could lead to open medical research focusing 
on pharmaceuticals for developing countries. The open innovation system suggested in 
this paper addresses the issue of the lagging R&D in most developing economies. Such 
important initiative could reduce the paradox in R&D with regard to local epidemics but 
requires more human resources that include larger number of medical doctors.  
As implied in series of publications, the introduction and development of advanced new 
technologies in health systems have induced further involvement of the private sector. 
This involvement is present in all areas of health, such as medical devices, 
pharmaceuticals and ways to perform surgery (Rettig, 1994), but also in the health system 
as a whole with the increasing presence of the private sector as a source of financing and 
in the system’s organization and institutions. The increasing involvement of the private 
sector comes as a response to the growing cost of health care and the need for trained 
doctors and specialists to cope with the ever changing technologies. Prior literature such 
as Berndt et al., (2000) and Cutler et al., (1999) identified that advances in medical 
technology increases the health costs such as costs of R&D, production costs or costs 
related to training technicians. In the US, annual costs rose from $297 per individual in 
1970 to $3632 in the late 90s (Cowan et al., 1999). The public sector alone could not bear 
the increase in expenditures, especially in developing countries, thus, the intervention of 
the private sector was vital. This emergence of the private sector in the area of health care 
has been creating new challenges to HCS but mainly to different categories of the human 
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resources operating in this sector but also in public hospitals and laboratories. 
Furthermore, as health care costs increase, further managerial and planning tools are 
needed. These trends have certainly induced the expansion of prevention 
but also diagnosis and curative health functions (WHO, 2010). The world health 
system has been progressively benefiting from the contribution of the new technologies 
(MedPac, 2004). Marfula and Winter (2015) provide evidence about the role played by 
information technology in healthcare through a literature review.  
The above technological and institutional changes have had major effects on the human 
resources in health. WHO (2006) estimates a total of 59.2 million full-time paid health 
workers worldwide. These human resources operate in health enterprises primary focused 
on health care provision but also in allied organizations. According to the same source, 
health service providers represent two thirds while workers in management constitute the 
remaining third of the global health workforce. Kent, Chopra, Dal Poz and Bennett 
(2010) consider that human resources account for approximately 70% of recurrent 
expenditure in most health systems. As it can be observed from the appendices, 
developed economies have higher numbers of doctors, pharmacists and other health 
workers. This is also expressed in the density measured per 1000 population.  But even 
with higher figures, the numbers are not that high compared to increasing needs of the 
populations and to the requirements imposed by advanced health technologies. 
Developing economies even with major variables do not exhibit satisfactory figures for 
both total and density of health workforce. Kent, Chopra, Dal Poz and Bennett (2010) 
show that since human resources account for approximately 70% of recurrent expenditure 
in most health systems, inadequate human resource training, regulation, distribution and 
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management can have enormous implications. These trends are related also to the 
interdependencies that exist between different medical specializations and then to the 
interferences among different health specialists. Murray and Osman, (2012) show that 
several challenges facing healthcare and where accounting for palliative practice is likely 
to have series of benefits. But, shortages in the human resources taking care in palliative 
medicine do negatively affect the health of patients and their families. This means that 
when accounting for medical specialties, the shortage can even be worse.  
II. Empirical Analysis and Results 
 
 There are many factors and trends that are affecting the shortages in medical 
doctors in developing economies. Emigration is the consequence of these factors that 
place pressure on domestic health systems.  
World Distribution of Benefits  
At all level of the health system, developed economies have appeared to be occupying 
dominant positions in production, use and trade of health care outputs issued from new 
technologies. As shown in Driouchi and Kadiri (2010), developed countries are also those 
that have control over different advanced technologies. But, the health benefits of these 
advances are clearly distributed worldwide and attain most world population.  
While developed countries have been ensuring means and instruments to provide full 
health coverage, this process is still limited in the developing world. Efforts involving 
different national and international organizations appear to be promoting new means to 
enhance the level of health benefits in these economies. The millennium development 
goals framework is a global framework devoted to series of actions to ensure the 
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attainment of some realistic objectives by 2015. While this overall trend has been 
developing, some emergent economies have been accelerating the process of production 
and use of the innovations from the new health system.  
Health Workforce Density per country  
The number of health workforce specialists per country in relation to the 
population of the country as represented by the density per 1000 people can be used as 
indicator of the availability per country. But, this is an overall average as different 
country, regional and global reports by World Health Organization discuss the spatial 
disparities in distribution of medical personnel.  
Regression analysis is conducted to show how different densities of different types of 
specialists are related. This exercise is conducted respectively for all countries, for the set 
integrating Arab and Central Eastern European economies (ECE), then for Arab and ECE 
countries.  
All Countries 
The following table 1 shows the best regressions obtained. Nursing and midwifery 
besides pharmaceutical personnel appear to have statistically significant effects with 
respective coefficients of 0.027 and 0.251. The related degrees of freedom are 102 with 
and R2 of 0.660. This implies that each unit of nursing adds 0.027 physicians while a one 
unit of pharmacist adds 0.251 physicians. The second regression (table 2) with only 62 
degrees of freedom and R2 of 0.611, shows that “laboratory health workers” exhibits also 
an effect that is statistically significant (0.480).  
Table 1: Overall Regression 
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Dependent 
Variables 
Independents 
Variables  
Values t-Stat R² Degrees of 
Freedom 
Physicians 
density (per 
1000 
population) 
 
(Constant) .133 2.528 .660 102 
Nursing and 
midwifery personnel 
density (per 1000 
population) 
.027 9.018 
Pharmaceutical 
personnel density 
(per 1000 
population) 
.251 4.931 
Physicians 
density (per 
1000 
population) 
 
(Constant) .139 1.170 .611 62 
Pharmaceutical 
personnel density 
(per 1000 
population) 
.449 2.012 
Laboratory health 
workers density (per 
1000 population) 
.480 4.890 
 
 
Arab and ECE countries 
But, the above global results are changed when looking at the results from the 
best regressions obtained from the sample of Arab countries and Eastern and Central 
European economies.  The two respective regressions have R2 of 0.765 and 0.301 with 26 
and 28 degrees of freedom. Nursing and dentistry have estimated coefficients of 0.044 
and 0.434 in the first regression. The second regression shows pharmaceuticals and 
laboratory workers respectively with coefficients of 0.354 and 0.358.  
Table 2: Regressions for Arab and ECE countries 
Dependent 
Variables 
Independents 
Variables  
Values t-Stat R² Degrees 
of 
Freedom 
 9 
Physicians 
density (per 
1000 
population) 
 
(Constant) .223 1.344 .765 26 
Nursing and 
midwifery personnel 
density (per 1000 
population) 
.044 4.337 
Dentistry personnel 
density (per 1000 
population) 
.434 3.803 
Physicians 
density (per 
1000 
population) 
(Constant) .235 5.784 .301 28 
Pharmaceutical 
personnel density 
(per 1000 population) 
.354 3.411 
Laboratory health 
workers density (per 
1000 population) 
.358 3.892 
 
 
Arab Countries 
With limited degrees of freedom, the density of physicians is statistically and 
significantly related to the nursing and midwifery density.  It is also related to the density 
of pharmacists but the other regressions show that the density of dentist has also a 
statistically significant explanatory power.  The same thing applies to explanatory 
variables such as laboratory health workers, environmental and public health workers 
besides other health workers.  
Table 3: Regression for Arab countries 
Dependent 
Variables 
Independents 
Variables  
Values t-Stat R² Degrees of 
Freedom 
Physicians 
density (per 
1000 
population) 
 
(Constant) .166 .624  
.979 
 
3 Nursing and 
midwifery 
personnel density 
(per 1000 
.096 
 
5.883 
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population) 
Health management 
& support workers 
density (per 1000 
population) 
.090 -2.265 
Physicians 
density (per 
1000 
population) 
 
(Constant) .166 4.493 .746 17 
Pharmaceutical 
personnel density 
(per 1000 
population) 
.222 6.848 
Physicians 
density (per 
1000 
population) 
 
(Constant) .207 3.022 .678 17 
Dentistry personnel 
density (per 1000 
population) 
.412 5.800 
Physicians 
density (per 
1000 
population) 
 
(Constant) .252 .520 .930 4 
Laboratory health 
workers density (per 
1000 population) 
.445 6.304 
Physicians 
density (per 
1000 
population) 
 
(Constant) 1.208 
 
-4.046 
 
.961 2 
Environmental and 
public health 
workers density (per 
1000 population) 
17.556 4.975 
Other health 
workers density (per 
1000 population) 
.247 .334 
Laboratory health 
workers density (per 
1000 population) 
.247 1.786 
      
 
ECE countries 
With also limited degrees of freedom, the density of physicians appears to be 
related mainly to health personnel in dentistry and to nursing.  
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Table 4: Regressions for ECE countries 
Dependent 
Variables 
Independents 
Variables  
Values t-Stat R² Degrees 
of 
Freedom 
Physicians 
density (per 
1000 
population) 
(Constant) .385 3.806 .506 13 
Dentistry personnel 
density (per 1000 
population) 
.721 3.506 
Physicians 
density (per 
1000 
population) 
(Constant) .753 1.363 .298 13 
Nursing and 
midwifery personnel 
density (per 1000 
population) 
.119 2.255 
 
The above results show how different densities related to different components of health 
workforce are inter-related. But, the variable related to physicians has more accurate role 
in determining the distribution of other components of health personnel.  
Further Evidence 
This starts with showing the effect of high technologies on health in developed and 
developing economies. The constraints related to new technologies in developing 
countries constitute the second component of this paragraph. 
Medical Human Resources 
Human capital is at the center of health care system (WHO, 2006). The number 
and quality of workers are positively associated with immunization coverage, outreach of 
primary care and infant, child and maternal survival. Naicker and Tutt (2009) emphasized 
the state of medical human resources in Africa and the world. According to this study, 
1.3% of the global health care workforce is devoted to 25% of the disease burden 
representing a shortage of 817,992 health workers in Africa. In 2008, Africa had 2.3 
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health workers (physicians and nurses) for 1,000 individuals when Europe and Americas 
had 18.9 and 24.3 respectively. When taking the number of physicians per 100,000 
people (HDR, 2007), while the highest number of physicians varies from 318 to 591, it is 
between 2 and 12 physicians per 100,000 people for the lowest number category. 
Besides, the limited number of medical schools put additional pressure on the available 
stock of physicians in the home country (FAIMER, 2010; WHO, 2010).  
Table 5: Examples of Emerging Diseases in Developed Countries (2008) 
 
 Diseases (number of reported cases) 
Countries Measles Pertussis Total 
Tetanus 
Tuberculosis Rubella 
Australia 65 14,435 4 299 38 
Belgium 98 260 2 311 5 
Canada 41 1,961 1 488  
France 604  8 1,222  
Germany 917   954  
Japan 11,015 6,753 123 8,995 303 
Spain 297 563 15 2,333 70 
Switzerland 2,022  1 64 12 
United 
Kingdom 
1,445 1,028 5 1,028 31 
United States  140 13,213 0 13,213 16 
% of the global 6% 25.5% 1% 1.4% 0.3% 
 
These deficits are due to the domestic increases in demand for and emigration of health 
human resources. Danon-Hersch and Paccaud (2005) considered that since human 
resources are affected by progress in technology, health care systems should improve 
education and training for medical human resources and for administrative and 
management. The increase in demand is also due to the expansion of medical coverage, 
the extension of hospitals and the shift from traditional medicine and aid systems to 
modern health systems (Ron, 2008). A study by Driouchi et al., (2009) shows the higher 
levels of interdependencies between health and education. While there are major needs 
for medical doctors and nurses, preferences for urban centers (Driouchi, 2008) as well as 
emigration to other countries are affecting the coverage rate which can be critical in some 
regions. Emigration of nurses and medical doctors is taking place under the effects of 
salary differential and living conditions (Driouchi & Kadiri, 2010).  
Table 6: Country of medical school of sub-Saharan African international medical 
graduates (IMGs) in the United States and Canada 
Country of training 
Number of 
African-
trained IMGs 
in USA 
Number of 
African-
trained IMGs 
in Canada 
Number of 
physicians 
remaining in 
home country 
% of total 
African-
trained now 
in USA or 
Canada 
Nigeria  2158 123 22 894 9 
South Africa  1943 1845 23 844 14 
Ghana  478 37 1210 30 
Ethiopia  257 9 1564 15 
Uganda  133 42 722 20 
Kenya  93 19 4001 3 
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Zimbabwe  75 26 1694 6 
Zambia  67 7 676 10 
Liberia  47 8 72 43 
Other 12 countries 83 35 12 912 1 
Total/Average 5334 2151 69 589 10 
 
Table 6 shows the extent of medical doctors’ emigration from sub-Saharan African 
countries to the US and Canada (10%). 
Evidence about the relationship between advanced technologies and knowledge  
 
It is widely known that developed countries are benefiting more from advanced 
technologies, relative to developing economies. One simple way to test for this evidence 
is to see how health is responsive to technologies at the overall and in each group of 
countries. Using technology indices such as the Global Innovation Index (GII) (INSEAD, 
2010), the Knowledge Economy Index (KEI) (World Bank Institute, 2010) and the 
measure of Technology Exports (TE) (World Bank Data, 2010). Only the first two 
indicators appear to exhibit statistically significant relationships with the life expectancy 
at birth, taken as a proxy for health performance (Table 7).  Estimations difficulties 
related to this regression have been tackled through using literacy rate per country as 
instrument for life expectancy at birth. 
Table 7: Responsiveness of health to technologies 
  GII KEI 
 
All 
Countries Developed Developing 
All 
Countries Developed Developing 
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Coefficient 0.42 0.18 0.48 0.25 0.18 0.24 
STD Error 0.05 0.02 0.17 0.02 0.01 0.04 
t-Stat 8.04 7.50 2.40 15.00 6.23 6.80 
R² 0.43 0.47 0.10 0.62 0.36 0.45 
Observations 130 66 64 141 71 70 
 
The results shown in the above Table 7 clearly indicate that life expectancy at birth is 
influenced by technologies. The coefficients of sensitivity are respectively 0.42 and 0.25 
for GII and KEI for all countries. For developed economies, the coefficient is 0.18 for 
both GII and KEI. But, given the estimated standard error for each coefficient, the levels 
of responses appear to not be different between countries. This implies that developed, 
developing and all countries exhibit the same coefficient as it is confirmed in Table 8 
with the calculated t-statistics. Therefore, only higher levels of the technology index (GII 
and KEI) determine higher life expectancy at birth in developed economies. With lower 
levels of technologies, lower life expectancies at birth are observed at the level of 
developing economies. 
Table 8: Comparisons of coefficients  
Comparisons/t-stat GII KEI 
all/developed 0.000733107 1.39925E-05 
all/developing 0.000161037 5.33488E-06 
Developed/developing 0.000802044 3.19934E-05 
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These results are confirmed when using healthy life expectancy at birth, overall mortality, 
mother and children mortality rates as respective measures of health performance. The 
results confirm that developing countries with limited access to high levels of 
technologies achieve lower levels of health performance.  
III. Discussion 
 
The pressure of tasks form health care, introduction of new technologies and 
participation to medical research is enlarged with the constraints described above. These 
limits create shortages in relation to the increasing and large demand. One of the means 
to address the above cited shortcomings is to move toward World Health Systems and 
global linkages, with connections to local areas and countries.  This is within a 
cooperative framework that has been already increasing between developed and 
developing countries (Gostin et al., 2010). International medical cooperation and access 
to the outcomes of advanced technologies will help reduce technology and research gaps 
between developed and developing countries. Neglected diseases should receive enough 
care from research labs especially that Reidpath et al., (2011) found that neglected 
tropical diseases (NTD) research is more related to biomedical area than to social 
sciences. Pokhrel et al., (2011) concluded that more social science based NTD research is 
needed and funding for it is not as low as it seems.  
Technological advancement and research should not be carried without considering 
the training of human factor implying that medical education is also linked to overall 
process of improving the health system. Therefore, national education systems should 
train more medical personnel to satisfy the increasing demand. It should also include 
integrated medical training and research. To enhance health knowledge and practice 
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globally, Ruger and Ng (2010) describe the roles that emerging countries play in 
supplying global health and redressing health inequities. 
Conclusion 
 The limitations affecting health care even, under higher development of new 
advanced worldwide technologies are likely to occur in the absence of the skills and size 
of the health workforce.  
These dimensions are developed in the present paper trough looking first, at the 
trends characterizing the world development of the new health system and its evolution 
under the impulse of new technologies. This is followed by an overall analysis of the 
major constraints facing developing economies. The relationships with the health 
workforce are addressed in the two sections.  
Within this context, the features related to the world development of new health 
technologies and practices under the effects of new technologies are reviewed. They 
consist in increases in the flows of outputs related to new technologies with their 
applications in health care, globally. But, these promising trends have generated 
important shifts where private interests have been increasingly involved in the new health 
care systems with expanded costs and higher financial requirements to every partner in 
the chain of the health system, including patients. The implied financial burden is shown 
to be leading to higher financial requirements and mainly to the expansion of social 
health care systems where private insurances are progressively developing. This leads to 
an increasing number of players concerned with the new health systems. While this is 
true for both developed and developing countries, some economies in the developing 
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world are finding their way out to ensure better health care systems in the emerging 
developing economies. But, other countries have more limitations in accessing and 
benefiting from the global system. 
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